531000 Sigma-AldrichBrk Inhibitor, Cpd 4f - Calbiochem
A cell permeable, highly potent, and very selective inhibitor of breast tumor kinase (Brk; IC₅₀ = 3.15 nM). Displays anti-proliferative activity against multiple breast cancer cell lines.
More>> A cell permeable, highly potent, and very selective inhibitor of breast tumor kinase (Brk; IC₅₀ = 3.15 nM). Displays anti-proliferative activity against multiple breast cancer cell lines. Less<<Synonyms: PTK6 Inhibitor, Breast Tumor Kinase Inhibitor
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Empirical Formula |
|---|
| C₁₇H₁₃N₃O |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 5.31000.0001 |
|
Glass bottle | 10 mg |
|
— |
| References | |
|---|---|
| References | Mahmoud, K. A., et al. 2014. Bioorg. Med. Chem. Lett. 24, 1948. |
| Product Information | |
|---|---|
| Form | Light beige powder |
| Hill Formula | C₁₇H₁₃N₃O |
| Chemical formula | C₁₇H₁₃N₃O |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Brk |
| Primary Target IC<sub>50</sub> | 3.15 nM |
| Purity | ≥97% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 5.31000.0001 | 04055977242485 |
Documentation
Brk Inhibitor, Cpd 4f - Calbiochem SDS
| Title |
|---|
References
| Reference overview |
|---|
| Mahmoud, K. A., et al. 2014. Bioorg. Med. Chem. Lett. 24, 1948. |
Brochure
| Title |
|---|
| NPI Flyer- Epigenetics and Nuclear Function Feature |
| New Products - Antibodies, Small Molecule, Inhibitors |
Technical Info
| Title |
|---|
| White Paper: Further considerations of antibody validation and usage. |



